Both are still in trials but 10 months with chemotherapy versus 2.4 months could bring the drug to the front view of the public, as has been done in the past with activists groups pushing for approval of other drugs. Both are different with treatment plans and the drugs would be limited to the...
Posted to
The Medical Quack .... by Barbara Duck
on 12-04-2008
Filed under: Medically Related, Pharma/FDA News, healthcare, Pharma, Cancer, clinical trials, Prostate Cancer, PSA, R and D, antigen, testosterone
When it comes to cancer today there are many different options to look at and discuss with your physician as to which option, depending on your diagnosis and condition would be the best plan, but as this article states, we really won’t know how effective some of the new technology really is until enough...
Posted to
The Medical Quack .... by Barbara Duck
on 11-28-2008
Filed under: Medically Related, Technology, healthcare, Cancer, Oncology, Prostate Cancer, PSA, Online Tools, Biopsy, Calculator, CyberKnife
According to the study, statins are lowering the PSA levels, but the concern is whether or not this could be hiding or clouding the issues and cancer could be potentially missed in the diagnosis as they are not sure if this is lowering the test numbers or if it is in fact helping in the prevention of...
Not available here in the US yet, but this is a genomic based test that is cancer specific. Nobody likes having a biopsy done by any means and this appears to be working in that direction, in other words more information available to perhaps avoid biopsies that are perhaps not required. BD...
The tool is designed for use by doctors and will still need to go through clinical trials to determine accuracy and effectiveness. This is a joint effort and will be tested at Harvard Medical School and the Cleveland Clinic. Radiation oncologists and urologists are the targeted physicians...
Posted to
The Medical Quack .... by Barbara Duck
on 09-24-2008
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, Cancer, Oncology, Prostate Cancer, PSA, Online Tools, Biopsy, Calculator
After all the recent news about the PSA test, here's a genomics answer. The MD Anderson Cancer Center, demonstrated a very high success rate for identifying the presence of Grade 3 or higher prostate cancer cells. The new prostate cancer test will be performed at Clarient's Clinical...
Posted to
The Medical Quack .... by Barbara Duck
on 08-07-2008
Filed under: Medically Related, Technology, Pharma/FDA News, Other Items of Interest, personalized medicine, DNA, Genomics, Prostate Cancer, Pharmacogenomics, PSA, Cancer Test
According to this article, a patch would transmit the results direct to a cell phone, more telemedicine in the works? If the efforts are successful, this would allow more to be tested though the technology as the results could be relayed back to the physician or hospital. Biotech at work...